CytexOrtho
Brad Estes
CEO & Founder

CytexOrtho is a clinical-stage regenerative orthopedics company focused on restoring joints rather than replacing them. Its first clinical asset, ReNew™ Hip, addresses a critical gap in hip preservation for young, active patients with joint damage who have few durable treatment options. These patients are often caught in a “missing middle” between earlier-stage arthroscopic procedures and later-stage total hip replacement. Arthroscopy can correct bone and labral pathology but cannot restore lost articular cartilage, while total hip replacement is premature given their age and activity level. Building on ReNew™ Hip, CytexOrtho is expanding its technology across multiple joints to establish a new category of orthopedic care for patients in this missing middle.